Cargando…
Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
This study investigated the genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-Sp) in Osogbo, southwest Nigeria. Blood sample was obtained from consenting pregnant women attending antenatal clinics. M...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Makerere Medical School
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398500/ https://www.ncbi.nlm.nih.gov/pubmed/37545953 http://dx.doi.org/10.4314/ahs.v23i1.80 |
_version_ | 1785084073979412480 |
---|---|
author | Olowe, Rita A Ojo, Johnson A Funwei, Roland I Oyedeji, Segun I Olowe, Olugbenga A Thomas, Bolaji N Ojurongbe, Olusola |
author_facet | Olowe, Rita A Ojo, Johnson A Funwei, Roland I Oyedeji, Segun I Olowe, Olugbenga A Thomas, Bolaji N Ojurongbe, Olusola |
author_sort | Olowe, Rita A |
collection | PubMed |
description | This study investigated the genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-Sp) in Osogbo, southwest Nigeria. Blood sample was obtained from consenting pregnant women attending antenatal clinics. Microscopy and Polymerase chain reaction (PCR) were employed to diagnose and analyse genetic diversity. Of the 301 samples, 53 (18%) and 83 (28%) were positive for P. falciparum by microscopy and PCR, respectively. Using the merozoite surface protein (msp)-1, msp-2, and glutamate-rich protein (glurp) genes of P. falciparum as polymorphic markers, the msp-1 gene showed nine alleles with R033 (66.7%) being predominant, followed by K1 (45.5%) and MAD20 (33.3%). The msp-2 gene had 16 alleles (eight each for FC27 and 3D7). The 3D7 alleles (82.1%) was significantly more than FC27 alleles (48.2%) (p = 0.0093). Nine alleles were detected with glurp gene, presenting with the highest monoclonal and the lowest polyclonal infection. The multiplicity of infection (MOI) of 1.5, 1.8, and 1.2 were obtained for msp-1, msp-2 and glurp genes. In light of the high P. falciparum genetic diversity among pregnant women on IPT-Sp in this study, additional strategies for preventing and controlling malaria in pregnancy might be required. |
format | Online Article Text |
id | pubmed-10398500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Makerere Medical School |
record_format | MEDLINE/PubMed |
spelling | pubmed-103985002023-08-04 Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria Olowe, Rita A Ojo, Johnson A Funwei, Roland I Oyedeji, Segun I Olowe, Olugbenga A Thomas, Bolaji N Ojurongbe, Olusola Afr Health Sci Articles This study investigated the genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-Sp) in Osogbo, southwest Nigeria. Blood sample was obtained from consenting pregnant women attending antenatal clinics. Microscopy and Polymerase chain reaction (PCR) were employed to diagnose and analyse genetic diversity. Of the 301 samples, 53 (18%) and 83 (28%) were positive for P. falciparum by microscopy and PCR, respectively. Using the merozoite surface protein (msp)-1, msp-2, and glutamate-rich protein (glurp) genes of P. falciparum as polymorphic markers, the msp-1 gene showed nine alleles with R033 (66.7%) being predominant, followed by K1 (45.5%) and MAD20 (33.3%). The msp-2 gene had 16 alleles (eight each for FC27 and 3D7). The 3D7 alleles (82.1%) was significantly more than FC27 alleles (48.2%) (p = 0.0093). Nine alleles were detected with glurp gene, presenting with the highest monoclonal and the lowest polyclonal infection. The multiplicity of infection (MOI) of 1.5, 1.8, and 1.2 were obtained for msp-1, msp-2 and glurp genes. In light of the high P. falciparum genetic diversity among pregnant women on IPT-Sp in this study, additional strategies for preventing and controlling malaria in pregnancy might be required. Makerere Medical School 2023-03 /pmc/articles/PMC10398500/ /pubmed/37545953 http://dx.doi.org/10.4314/ahs.v23i1.80 Text en © 2023 Olowe RA et al. https://creativecommons.org/licenses/by/4.0/Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Olowe, Rita A Ojo, Johnson A Funwei, Roland I Oyedeji, Segun I Olowe, Olugbenga A Thomas, Bolaji N Ojurongbe, Olusola Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria |
title | Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria |
title_full | Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria |
title_fullStr | Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria |
title_full_unstemmed | Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria |
title_short | Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria |
title_sort | genetic diversity of plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in nigeria |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398500/ https://www.ncbi.nlm.nih.gov/pubmed/37545953 http://dx.doi.org/10.4314/ahs.v23i1.80 |
work_keys_str_mv | AT oloweritaa geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria AT ojojohnsona geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria AT funweirolandi geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria AT oyedejiseguni geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria AT oloweolugbengaa geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria AT thomasbolajin geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria AT ojurongbeolusola geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria |